Back to results
CompletedPhase 2

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

NCT02244541

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Melbourne Health - The Royal Melbourne Hospital

Melbourne, Victoria, Australia

+4 additional locations

View on ClinicalTrials.gov
Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease — TrialFind